← 返回

程序性死亡配体 1 与 TIL(肿瘤浸润淋巴细胞)(TILs):低 TIL 密度可能预示 T1 期喉癌更差的长期预后

英文原题:Programmed death-ligand 1 and tumor-infiltrating lymphocytes (TILs) - low TIL density may predict poorer long-term prognosis in T1 laryngeal cancer.

查看英文原题

Programmed death-ligand 1 and tumor-infiltrating lymphocytes (TILs) - low TIL density may predict poorer long-term prognosis in T1 laryngeal cancer.

PubMed 2023/07/18(内容时间) Virchows Arch Q2 · IF 3(JCR 2025)

分数与星级只用于站内排序 —— 不代表疗效、安全性或个人适用性。

中文摘要

我们评估了程序性死亡配体1(PD-L1)和TIL(肿瘤浸润淋巴细胞)(TILs)在T1声门型喉鳞状细胞癌(LSCC)中的预后作用。纳入2003年至2013年间在五家芬兰大学医院接受治疗的T1声门型LSCC患者(n = 174)。使用组织微阵列(TMA)模块进行PD-L1免疫组化染色。TILs从全组织切片的肿瘤内和间质区域进行评分。在174例患者中,92例(53%)PD-L1水平为阴性,66例(38%)为中等,16例(9%)为高表达。在80例分析了TILs的患者中,50例(63%)间质TIL密度低,30例(38%)间质TIL密度高。发生局部复发或喉部新原发肿瘤的患者TIL密度低于其他患者(p = 0.047)。高PD-L1表达合并低间质TIL密度与较差的5年疾病特异性生存相关(85% vs. 100%,p = 0.02)。

总之,在接受T1声门型LSCC治疗的患者中,低间质TIL密度与局部复发和喉部新原发肿瘤相关。高PD-L1表达合并低间质TIL密度可能与T1声门型LSCC较差的生存相关。

展开英文摘要原文

We evaluated the prognostic role of programmed death-ligand 1 (PD-L1) and tumor-infiltrating lymphocytes (TILs) in T1 glottic laryngeal squamous cell carcinoma (LSCC). T1 glottic LSCC patients (n = 174) treated at five Finnish university hospitals between 2003 and 2013 were included. Tissue microarray (TMA) blocks were used for PD-L1 immunohistochemistry. TILs were scored from intratumoral and stromal regions in whole tissue sections.

Of 174 patients, 92 (53%) had negative, 66 (38%) intermediate, and 16 (9%) high PD-L1 levels. Of 80 patients whose TILs were analyzed, 50 (63%) had low and 30 (38%) high stromal TIL density. Patients with a local recurrence or a new primary tumor of the larynx had lower TIL density than had other patients (p = 0. 047). High PD-L1 expression with low stromal TIL density was associated with inferior 5-year disease-specific survival (85% vs. 100%, p = 0. 02).

In conclusion, in patients treated for T1 glottic LSCC, low stromal TIL density was associated with local recurrences and new primary tumors of the larynx. High PD-L1 expression with low stromal TIL density may be associated with worse survival in T1 glottic LSCC.

论文信息

作者
Pakkanen P、Ilmarinen T、Halme E、Irjala H、Koivunen P、Pukkila M、Ventelä S、Almangush A
单位
Department of Otorhinolaryngology - Head and Neck Surgery, University of Helsinki and Helsinki University Hospital, Helsinki, Finland. pihla.pakkanen@helsinki.fi.Finland
期刊
Virchows Archiv : an international journal of pathology2024 Aug
原文标识
PubMed 37462760 · DOI 10.1007/s00428-023-03586-7